Csenge Advisory Group’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $809K | Buy |
9,559
+28
| +0.3% | +$2.26K | 0.03% | 366 |
|
|
2026
Q1 | $674K | Sell |
9,531
-325
| -3% | -$24.3K | 0.03% | 378 |
|
|
2025
Q4 | $778K | Sell |
9,856
-96
| -1% | -$7.6K | 0.04% | 349 |
|
|
2025
Q3 | $820K | Sell |
9,952
-2,416
| -20% | -$190K | 0.04% | 332 |
|
|
2025
Q2 | $972K | Sell |
12,368
-1,279
| -9% | -$98.7K | 0.05% | 270 |
|
|
2025
Q1 | $990K | Buy |
13,647
+131
| +1% | +$10.9K | 0.06% | 249 |
|
|
2024
Q4 | $1.11M | Buy |
13,516
+1,095
| +9% | +$91.1K | 0.06% | 250 |
|
|
2024
Q3 | $1.06M | Sell |
12,421
-336
| -3% | -$25.1K | 0.06% | 255 |
|
|
2024
Q2 | $895K | Sell |
12,757
-296
| -2% | -$21.1K | 0.05% | 277 |
|
|
2024
Q1 | $967K | Buy |
13,053
+374
| +3% | +$26.1K | 0.05% | 270 |
|
|
2023
Q4 | $838K | Buy |
12,679
+450
| +4% | +$28.2K | 0.05% | 270 |
|
|
2023
Q3 | $769K | Sell |
12,229
-1,687
| -12% | -$105K | 0.05% | 264 |
|
|
2023
Q2 | $787K | Buy |
13,916
+845
| +6% | +$46.9K | 0.05% | 268 |
|
|
2023
Q1 | $757K | Sell |
13,071
-3,817
| -23% | -$258K | 0.05% | 258 |
|
|
2022
Q4 | $1.22M | Buy |
16,888
+93
| +0.6% | +$6.66K | 0.09% | 186 |
|
|
2022
Q3 | $1.02M | Sell |
16,795
-1,442
| -8% | -$92.1K | 0.08% | 198 |
|
|
2022
Q2 | $1.15M | Sell |
18,237
-130
| -0.7% | -$8.61K | 0.1% | 185 |
|
|
2022
Q1 | $1.29M | Sell |
18,367
-2,370
| -11% | -$160K | 0.1% | 174 |
|
|
2021
Q4 | $1.25M | Sell |
20,737
-188
| -0.9% | -$11.8K | 0.11% | 157 |
|
|
2021
Q3 | $1.31M | Buy |
20,925
+188
| +0.9% | +$11.3K | 0.11% | 168 |
|
|
2021
Q2 | $1.25M | Buy |
20,737
+8,625
| +71% | +$547K | 0.11% | 157 |
|
|
2021
Q1 | $750K | Buy |
12,112
+4,186
| +53% | +$231K | 0.08% | 195 |
|
|
2020
Q4 | $372K | Buy |
7,926
+934
| +13% | +$40.5K | 0.04% | 281 |
|
|
2020
Q3 | $268K | Sell |
6,992
-15,892
| -69% | -$603K | 0.04% | 314 |
|
|
2020
Q2 | $836K | Buy |
22,884
+8,244
| +56% | +$287K | 0.12% | 136 |
|
|
2020
Q1 | $448K | Buy |
14,640
+2,119
| +17% | +$94K | 0.12% | 157 |
|
|
2019
Q4 | $638K | Buy |
12,521
+3,411
| +37% | +$165K | 0.16% | 124 |
|
|
2019
Q3 | $429K | Sell |
9,110
-1,853
| -17% | -$88.3K | 0.12% | 163 |
|
|
2019
Q2 | $544K | Buy |
+10,963
| New | +$515K | 0.19% | 90 |
|
|
2018
Q4 | – | Sell |
-106
| Closed | -$4K | – | 944 |
|
|
2018
Q3 | $4K | Buy |
+106
| New | +$4.84K | ﹤0.01% | 650 |
|
Other funds holding MET
Csenge Advisory Group's MET Position: Q2 2026 in Review
Csenge Advisory Group increased its MetLife (MET) stake by 0.29% in Q2 2026, buying an estimated $2.26K and bringing the position to 9,559 shares worth $809K. The position accounts for 0.03% of the portfolio, ranked #366.
Csenge Advisory Group first reported a position in MET in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.31M in Q3 2021. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Csenge Advisory Group held 9,559 shares of MetLife worth $809K as of Q2 2026.
- Csenge Advisory Group bought 28 MetLife shares in Q2 2026, an estimated $2.26K.
- MetLife made up 0.03% of Csenge Advisory Group's portfolio in Q2 2026, its #366 holding.
- Csenge Advisory Group first reported a position in MetLife in Q3 2018 and has held it in 30 quarters since.
- Csenge Advisory Group's MetLife position peaked at $1.31M in Q3 2021.
- 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.